H5N1 Avian Influenza
A highly pathogenic influenza A subtype entrenched in US dairy cattle and wild birds globally, with a historic 46% human case fatality rate and sustained pandemic concern.
Add to a list
No lists yet.
What it is
H5N1 is a subtype of influenza A virus classified as highly pathogenic avian influenza (HPAI). "Highly pathogenic" refers to its near-total lethality in infected poultry flocks; it does not predict severity in every human case, though documented human infections carry a historic case fatality rate near 46%. The virus belongs to the H5N1 lineage traceable to a 1996 goose isolate from Guangdong, China; the clade currently dominating global spread, 2.3.4.4b, emerged around 2020 and has since displaced earlier lineages. WHO, WOAH, and FAO track it jointly as one of the highest-priority zoonotic pandemic threats under active surveillance.
History
The first human cases appeared in Hong Kong in 1997: 18 infections, 6 deaths. Hong Kong authorities culled approximately 1.5 million poultry within three days, ending that outbreak. H5N1 re-emerged in 2003 and spread steadily from Asia to Europe and Africa across the 2000s and 2010s. A cumulative WHO tally published in January 2026 records more than 1,000 confirmed human cases globally since 1997, with roughly half proving fatal, across 23 countries. The modern phase began when clade 2.3.4.4b emerged around 2020 and drove a global bird-die-off of unprecedented scale, encompassing hundreds of millions of poultry. The virus reached South America in 2021 via migratory birds and was confirmed in Antarctic wildlife by 2023, establishing itself on every inhabited continent and in marine ecosystems. In 2024, it crossed into US dairy cattle, a novel mammalian reservoir, reshaping global risk calculations. On 20 June 2026, Australia confirmed its first detection in a wild seabird near Esperance, Western Australia, closing the last major H5-free continental gap.
Current state
As of early July 2026, clade 2.3.4.4b is the globally dominant strain. In the United States, the outbreak in dairy cattle has affected more than 500 herds across 15 states since early 2024, with California bearing the largest share. The US Centers for Disease Control and Prevention counts 71 confirmed human cases since February 2024, nearly all mild and linked to occupational exposure at dairy or poultry facilities, with one fatality. No sustained person-to-person transmission has been confirmed anywhere in the world. WHO, FAO, and WOAH maintain a joint assessment placing the current global human risk at low. Australia's June 2026 detection, documented in H5 bird flu reaches Australia, the last continent to fall, in a migratory skua, has prompted heightened biosecurity monitoring across Pacific-rim nations. The US outbreak's food-supply and food-price dimensions are tracked in H5N1 grinds on across US poultry and dairy as summer detections mount.
Relationships
WHO leads human-risk surveillance and pandemic-preparedness coordination, holding manufacturing agreements with 15 vaccine producers for rapid scale-up if a pandemic is declared. FAO and WOAH lead on the animal-health side, publishing joint HPAI situation reports every six to eight weeks. The US Department of Agriculture manages on-farm outbreak responses in the United States. China, Indonesia, Egypt, Vietnam, and Cambodia have historically accounted for most confirmed human deaths; as of mid-2026, Bangladesh, Cambodia, and India have reported additional human cases. Dairy cattle are now an established mammalian host in the United States, a structural change that prolongs virus circulation and increases the statistical chance of adaptive mutations.
What to watch
The central risk is acquisition of efficient human-to-human transmission, which would trigger a pandemic declaration under International Health Regulations. Scientists are monitoring sequence data from US dairy-cattle isolates for receptor-binding domain mutations that favor attachment to human upper-airway receptors. WHO and US public-health agencies are watching whether farm-worker surveillance captures cases before any transmission chains form. Vaccine candidates targeting clade 2.3.4.4b are in clinical trials in several countries, but global manufacturing timelines remain measured in months. Australia's response to its first detections will test whether a late-arriving nation can prevent H5N1 from entering commercial poultry. The FAO-WOAH-WHO joint risk assessments, published roughly bimonthly, are the primary early-warning signal to monitor.